Federal court rejects PhRMA challenge to Medicare drug price negotiation
A federal appeals court on Wednesday ruled against a lawsuit filed by representatives of the pharmaceutical industry challenging the federal Medicare drug price negotiation program, finding that drugmakers are not entitled to sell their products to Medicare at a price they would prefer. The U.S. Court of Appeals for the Fifth Circuit affirmed a prior...
We haven't written up this one. The Hill has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
